John Wiley & Sons Inc. (NYSE: JWa, JWb) is continuing an acquisition streak, and has picked up SimBioSys for an undisclosed amount.

SimBioSys provides scientific software that aims to help with the drug discovery process. The Toronto, Canada-based company’s software is used primarily by chemists.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.